FIELD: chemistry.
SUBSTANCE: invention relates to a compound of the general formula
,
where R is a saturated linear or branched hydrocarbon chain of atoms.
EFFECT: new compound has been obtained, which is characterized by increased resistance and can be used in medicine to inhibit platelet aggregation.
2 cl, 4 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIPLATELET | 2023 |
|
RU2808529C1 |
| COMPOUND REACTING WITH THIOL CLUSTER OF ATOMS AND INHIBITING THROMBOCYTE FUNCTION | 2010 |
|
RU2452727C1 |
| SUBSTANCE INHIBITING FUNCTIONS OF PLATELETS | 2008 |
|
RU2382764C1 |
| AGENT FOR INHIBITION OF PLATELET ACTIVITY | 1998 |
|
RU2161483C2 |
| AGENT POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2696583C1 |
| REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
| 2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
| AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
| METHOD OF EVALUATING THE EFFECTIVENESS OF NON-AGGREGATE PREPARATIONS AFFECTING THE METABOLISM OF ARACHIDONIC ACID BY INHIBITION OF CYCLOOXYGENASE-1 BOTH INDIVIDUALLY AND JOINTLY WITH ADP P2Y RECEPTOR ANTAGONIST ON PLATELET MEMBRANES OF THE BLOOD TO THE PATIENT RECEIVING NON-AGGREGATE PREPARATIONS | 2010 |
|
RU2442167C1 |
| METHOD OF EARLY PREDICTION OF RISK OF DEVELOPING VASCULAR INVOLVEMENTS IN ONSET OF ENDOCRINOPATHIES | 2010 |
|
RU2426123C1 |
